Skip to content
Recall Observatory FDA recall evidence

Drug product

Oxacillin for Injection, USP, 2 grams per vial, For IV or IM Use, Rx only, labeled as a) NDC 25021-162-24 and b) novaplus NDC 25021-162-68, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India.

D-0936-2023

July 11, 2023

Class II

Product summary

Firm
Sagent Pharmaceuticals
Event
Event 92678
Status
Ongoing
Classification
Class II
Quantity
65,710 vials for 1 g and 2 g strength
Official record key
drug-enforcement:D-0936-2023

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot #: a) OXL202, exp 6/30/2025; OXL204, exp 6/30/2025; OXL301, exp 12/31/2025; OXL205, exp 11/30/2025; b) OXL201, exp 5/31/2025; OXL203, exp 6/30/2025

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility